risperidone has been researched along with methylphenidate in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.75) | 18.2507 |
| 2000's | 23 (40.35) | 29.6817 |
| 2010's | 29 (50.88) | 24.3611 |
| 2020's | 4 (7.02) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sternlicht, HC; Wells, SR | 1 |
| Collins, L; Silver, BV; Zidek, KA | 1 |
| Hume, JH; Kowatch, RA; Kromelis, M; Sethuraman, G; Weinberg, WA | 1 |
| Aman, MG; Binder, C; Turgay, A | 1 |
| McDougle, CJ | 1 |
| Aubry, JM; Bertschy, G; Bryois, C; Eliez, S; Etter, M; Nanzer, N | 1 |
| Benjamin, E; Salek, S | 1 |
| Alvares, JP; Aman, M; Bodanese, R; Correia Filho, AG; Rohde, LA; Silva, TL | 1 |
| Aman, MG; Arnold, LE; Cronin, P; Dimitropoulos, A; Ghuman, J; Grados, M; Koenig, K; Lam, KS; McCracken, JT; McDougle, CJ; McGough, J; Posey, DJ; Ritz, L; Scahill, L; Swiezy, NB; Tierney, E; Vitiello, B; Williams, SK | 1 |
| Sabuncuoglu, O | 1 |
| Calil, HM; Justo, LP; Muszkat, M; Prado-Bolognani, SA | 1 |
| Armenteros, JL; Davalos, M; Lewis, JE | 1 |
| Aman, MG; Arnold, LE; Gadow, KD; Lecavalier, L; McCracken, JT; McDougle, CJ; Scahill, L; Sukhodolsky, DG; Tierney, E; Vitiello, B; Williams White, S | 1 |
| Hollis, CP; Thompson, A | 1 |
| Egger, HL; Emslie, GJ; Gleason, MM; Greenhill, LL; Kowatch, RA; Lieberman, AF; Luby, JL; Owens, J; Scahill, LD; Scheeringa, MS; Stafford, B; Wise, B; Zeanah, CH | 1 |
| Barton, R | 1 |
| van der Wal, KG; Willemsen, MA | 1 |
| Barzman, DH; Findling, RL | 1 |
| Findling, RL | 1 |
| Banaschewski, T; Becker, K; Poustka, L; Rothermel, B | 1 |
| Calarge, CA; Turner, CA; Xie, D; Zimmerman, BM | 1 |
| Ekinci, O; Sabuncuoglu, O | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Fattal-Valevski, A; Goldberg-Stern, H; Kramer, U; Schneebaum-Sender, N | 1 |
| Bachmann, CJ; Glaeske, G; Hoffmann, F; Kamp-Becker, I; Manthey, T | 1 |
| Blader, JC | 1 |
| Barr, AM; Elbe, D; Honer, WG; Procyshyn, RM | 1 |
| Body-Lawson, F; Didelot, N; Glay-Ribau, C; Javelot, H; Kabuth, B; Ligier, F; Messaoudi, M; Socha, M; Weiner, L | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Hsia, Y; Wong, IC | 1 |
| Aracil-Fernández, A; Berbel, P; Manzanares, J; Navarrete, F; Navarro, D; Ortega-Álvaro, A | 1 |
| Findling, RL; Ji, NY | 1 |
| Garcia, SS; Pérez, CA; Yu, RD | 1 |
| Ahmadpanah, M; Akbarian, S; Bajoghli, H; Brand, S; Haghighi, M; Holsboer-Trachsler, E; Jahangard, L; Keshavarzi, A; Sadeghi Bahmani, D | 1 |
| Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R | 1 |
| Manfredi, A; Masi, G; Milone, A; Muratori, P; Nieri, G; Pfanner, C | 1 |
| Naguy, A | 2 |
| Anagnostou, E | 1 |
| Gnanavel, S | 1 |
| Effatpanah, M; Khoramizadeh, M; Mahjoub, A; Mostaghimi, A; Rezaei, M; Shishehgar, S | 1 |
| Ayman, A; Kremer, AK; van den Akker, M; Yakubov, R | 1 |
| Burden, AM; Stämpfli, D; Weiler, S | 1 |
| Alamiri, B; Naguy, A | 1 |
| Aprigio, D; Basile, LF; Bastos, VH; Bittencourt, J; Budde, H; Cagy, M; Gongora, M; Marinho, V; Ribeiro, P; Teixeira, S; Velasques, B | 1 |
13 review(s) available for risperidone and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Psychiatry].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Lamotrigine; Mental Disorders; Methylphenidate; Piperazines; Quinolones; Risperidone; Triazines | 2005 |
Psychopharmacological treatment for very young children: contexts and guidelines.
Topics: Algorithms; Amphetamines; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child Psychiatry; Child, Preschool; Drug Prescriptions; Humans; Mental Disorders; Methylphenidate; Propylamines; Psychopharmacology; Risperidone | 2007 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
Pharmacological treatment of pathologic aggression in children.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Child; Drug Prescriptions; Health Status; Humans; Lithium Carbonate; Methylphenidate; Olanzapine; Risperidone; Time Factors; Valproic Acid; Violence | 2008 |
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2008 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder?
Topics: Age of Onset; Anticonvulsants; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Electroencephalography; Epilepsy; Epilepsy, Rolandic; Female; Humans; Infant; Male; Methylphenidate; Retrospective Studies; Risperidone | 2012 |
Pharmacotherapy for mental health problems in people with intellectual disability.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Human Growth Hormone; Humans; Intellectual Disability; Lithium Compounds; Mental Disorders; Methylphenidate; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone | 2016 |
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders | 2018 |
Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Topics: Amphetamine-Related Disorders; Aripiprazole; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Iran; Methylphenidate; Risperidone | 2019 |
One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.
Topics: CDC2 Protein Kinase; Chelating Agents; DNA Mutational Analysis; Female; Humans; Infant; Intellectual Disability; Methylphenidate; Mutation, Missense; Polystyrenes; Pseudohypoaldosteronism; Psychomotor Disorders; Receptors, Mineralocorticoid; Risperidone; Serotonin Antagonists | 2019 |
Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.
Topics: Attention Deficit Disorder with Hyperactivity; Combined Modality Therapy; Comorbidity; Conduct Disorder; Databases, Factual; Humans; Methylphenidate; Movement Disorders; Pharmacovigilance; Risperidone; World Health Organization | 2021 |
8 trial(s) available for risperidone and methylphenidate
| Article | Year |
|---|---|
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Carbamazepine; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Prospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2003 |
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Topics: Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Body Mass Index; Body Weight; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intelligence; Intelligence Tests; Male; Methylphenidate; Pemoline; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 2004 |
Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Female; Humans; Intellectual Disability; Male; Methylphenidate; Risperidone | 2005 |
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
Topics: Antipsychotic Agents; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Double-Blind Method; Female; Humans; Male; Methylphenidate; Obsessive-Compulsive Disorder; Reproducibility of Results; Risperidone; Severity of Illness Index; Surveys and Questionnaires | 2006 |
Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.
Topics: Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Pilot Projects; Risperidone; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical t
Topics: Adjuvants, Pharmaceutic; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Body Weight; Central Nervous System Stimulants; Child; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Risperidone; Treatment Outcome; Weight Gain | 2017 |
A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.
Topics: Aggression; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Humans; Italy; Male; Methylphenidate; Risperidone | 2017 |
Methylphenidate decreases the EEG mu power in the right primary motor cortex in healthy adults during motor imagery and execution.
Topics: Adult; Cross-Over Studies; Electroencephalography; Humans; Imagination; Methylphenidate; Motor Cortex; Movement; Risperidone | 2021 |
36 other study(ies) available for risperidone and methylphenidate
| Article | Year |
|---|---|
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Risperidone in childhood schizophrenia.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Drug Therapy, Combination; Humans; Isoxazoles; Male; Methylphenidate; Piperidines; Risperidone; Schizophrenia; Treatment Outcome | 1995 |
Risperidone treatment of motor restlessness following anoxic brain injury.
Topics: Adolescent; Amantadine; Brain Injuries; Dopamine Agents; Drug Therapy, Combination; Humans; Hypoxia, Brain; Male; Methylphenidate; Psychomotor Agitation; Risperidone; Serotonin Antagonists; Treatment Outcome | 2003 |
Methylphenidate an effective treatment for ADHD?
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonidine; Diagnostic Errors; Guanfacine; Humans; Male; Medication Errors; Methylphenidate; Risperidone | 2004 |
Stimulant-atypical antipsychotic interaction and acute dystonia.
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Dystonic Disorders; Humans; Male; Methylphenidate; Risperidone; Substance Withdrawal Syndrome; Tourette Syndrome; Violence | 2005 |
Risperidone-to-methylphenidate switch reaction in children: three cases.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Conduct Disorder; Drug Interactions; Female; Humans; Irritable Mood; Male; Methylphenidate; Psychomotor Agitation; Risperidone; Sensory Receptor Cells | 2007 |
Kleine-Levin syndrome: interface between neurology and psychiatry.
Topics: Adolescent; Antipsychotic Agents; Humans; Kleine-Levin Syndrome; Lithium Compounds; Male; Methylphenidate; Neuropsychological Tests; Polysomnography; Risperidone | 2007 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognition Disorders; Comorbidity; Cross-Over Studies; Double-Blind Method; Female; Humans; Intelligence; Language Development Disorders; Male; Methylphenidate; Personality Assessment; Randomized Controlled Trials as Topic; Risperidone; Social Behavior; Stereotyped Behavior | 2008 |
Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
Topics: Acute Disease; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dopamine Agonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Male; Methylphenidate; Receptors, Dopamine; Retreatment; Risperidone | 2007 |
[Medication-induced mandibular luxation in a seven-year-old patient].
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dopamine Uptake Inhibitors; Dystonia; Humans; Joint Dislocations; Male; Mandible; Methylphenidate; Risperidone | 2008 |
A washout period needed before switching from a neuroleptic to an amphetamine.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Drug Interactions; Humans; Methylphenidate; Psychomotor Agitation; Risperidone | 2009 |
[Bipolar disorders as co-morbidity in childhood and adolescence--underdiagnosed or overinterpreted? Therapy of a 14-year-old boy with hyperkinetic conduct disorder and hypomania].
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Bipolar Disorder; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Conduct Disorder; Cross-Cultural Comparison; Education; Hospitalization; Humans; International Classification of Diseases; Irritable Mood; Male; Methylphenidate; Patient Care Team; Psychotherapy; Risperidone; Social Behavior Disorders; Substance-Related Disorders | 2010 |
Academy of Medicine Singapore-Ministry of Health clinical practice guidelines: Autism Spectrum Disorders in pre-school children.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Benzodiazepines; Central Nervous System Stimulants; Child Development Disorders, Pervasive; Child, Preschool; Dopamine Antagonists; Humans; Mass Screening; Methylphenidate; Olanzapine; Prognosis; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Singapore | 2010 |
Iron status in toddlerhood predicts sensitivity to psychostimulants in children.
Topics: Anemia, Iron-Deficiency; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Infant; Male; Methylphenidate; Risperidone; Treatment Outcome | 2012 |
Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Humans; Male; Methylphenidate; Piperazines; Psychoses, Substance-Induced; Quinolones; Risperidone | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Germany; Humans; Infant; Infant, Newborn; Male; Methylphenidate; Prevalence; Risperidone; United States; Valproic Acid; Young Adult | 2013 |
Not just another antipsychotic-for-conduct-problems trial.
Topics: Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Drug Synergism; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2014 |
Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
Topics: Aggression; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Humans; Male; Methylphenidate; Risperidone | 2014 |
Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Conduct Disorder; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Treatment Outcome | 2014 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Authors' response to Bachmann and Hoffman's comments on psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.
Topics: Child Development Disorders, Pervasive; Female; Humans; Male; Methylphenidate; Risperidone; Valproic Acid | 2015 |
Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.
Topics: Animals; Cannabinoid Receptor Antagonists; Central Nervous System Agents; Cerebral Cortex; Cholecystokinin; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Immunohistochemistry; Male; Methylphenidate; Mice, Knockout; Neurons; Parvalbumins; Peptide Fragments; Piperidines; Prepulse Inhibition; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Risperidone; Time Factors | 2015 |
Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
Topics: Adolescent; Antipsychotic Agents; Basal Ganglia Diseases; Central Nervous System Stimulants; Drug Therapy, Combination; Humans; Male; Methylphenidate; Risperidone | 2016 |
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Female; Food Addiction; Hallucinations; Haloperidol; HLA-DQ beta-Chains; Humans; Learning Disabilities; Methylphenidate; Modafinil; Narcolepsy; Orexins; Pediatric Obesity; Polysomnography; Psychotic Disorders; Risperidone; Sleep Deprivation; Sleep Latency; Social Isolation; Sodium Oxybate; Suicidal Ideation | 2017 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome | 2017 |
Tardive Oculogyric Crisis With Low-Dose Antipsychotic in an Adolescent: A Case Report.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Conduct Disorder; Humans; Male; Methylphenidate; Ocular Motility Disorders; Risperidone; Tardive Dyskinesia | 2018 |
Methylphenidate-Induced Persistent Hiccups in a Child With ADHD Relieved by Add-On Risperidone.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Hiccup; Humans; Methylphenidate; Risperidone | 2020 |
ADHD Masquerading as Cautopyreiophagia Exacerbated by Risperidone and Improved With Methylphenidate in a Preschooler.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Risperidone; Treatment Outcome | 2021 |